Literature DB >> 15734795

The cytokine activity of HMGB1.

Huan Yang1, Haichao Wang, Christopher J Czura, Kevin J Tracey.   

Abstract

High mobility group box 1 (HMGB1) is a highly conserved, ubiquitous protein present in the nuclei and cytoplasm of nearly all cell types. We recently discovered that HMGB1 is secreted into the extracellular milieu and acts as a proinflammatory cytokine. Administration of HMGB1 to normal animals causes inflammatory responses, including fever, weight loss and anorexia, acute lung injury, epithelial barrier dysfunction, arthritis, and death. Anti-HMGB1 treatment, with antibodies or specific antagonists, rescues mice from lethal endotoxemia or sepsis and ameliorates the severity of collagen-induced arthritis and endotoxin-induced lung injury. Here, we give an abridged review of the cytokine activity of HMGB1, its secretion and release into the extracellular milieu, the putative signal transduction pathways, including interaction with cell-surface receptors and intracellular signaling, and its role in several inflammatory diseases. Finally, the therapeutic potential of blocking HMGB1 in the treatment of inflammatory diseases is discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15734795     DOI: 10.1189/jlb.1104648

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  194 in total

Review 1.  Hypothalamic inflammation and thermogenesis: the brown adipose tissue connection.

Authors:  Ana Paula Arruda; Marciane Milanski; Licio A Velloso
Journal:  J Bioenerg Biomembr       Date:  2011-02       Impact factor: 2.945

2.  Macrophage activation by factors released from acetaminophen-injured hepatocytes: potential role of HMGB1.

Authors:  Ana-Cristina Dragomir; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2011-04-14       Impact factor: 4.219

3.  High mobility group box protein-1 crossing cell borders may incite an inflammatory "tornado" in renal disease.

Authors:  V Shpacovitch; P R Mertens
Journal:  Int Urol Nephrol       Date:  2010-10-02       Impact factor: 2.370

4.  Chronic kidney disease worsens sepsis and sepsis-induced acute kidney injury by releasing High Mobility Group Box Protein-1.

Authors:  Asada Leelahavanichkul; Yuning Huang; Xuzhen Hu; Hua Zhou; Takayuki Tsuji; Richard Chen; Jeffrey B Kopp; Jürgen Schnermann; Peter S T Yuen; Robert A Star
Journal:  Kidney Int       Date:  2011-08-10       Impact factor: 10.612

Review 5.  Brain-peripheral cell crosstalk in white matter damage and repair.

Authors:  Kazuhide Hayakawa; Eng H Lo
Journal:  Biochim Biophys Acta       Date:  2015-08-13

6.  Extracellular proteome of human hepatoma cell, HepG2 analyzed using two-dimensional liquid chromatography coupled with tandem mass spectrometry.

Authors:  Ryo Yamashita; Yuko Fujiwara; Kohei Ikari; Keiko Hamada; Asuka Otomo; Kazuki Yasuda; Mitsuhiko Noda; Yasushi Kaburagi
Journal:  Mol Cell Biochem       Date:  2006-11-16       Impact factor: 3.396

7.  Anti-inflammatory effects of hyperoside in human endothelial cells and in mice.

Authors:  Sae-Kwang Ku; Wei Zhou; Wonhwa Lee; Min-Su Han; MinKyun Na; Jong-Sup Bae
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

8.  Orientin inhibits HMGB1-induced inflammatory responses in HUVECs and in murine polymicrobial sepsis.

Authors:  Hayoung Yoo; Sae-Kwang Ku; Taeho Lee; Jong-Sup Bae
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

9.  High-mobility group box 1 from reactive astrocytes enhances the accumulation of endothelial progenitor cells in damaged white matter.

Authors:  Kazuhide Hayakawa; Nobukazu Miyamoto; Ji Hae Seo; Loc-Duyen D Pham; Kyu-Won Kim; Eng H Lo; Ken Arai
Journal:  J Neurochem       Date:  2012-12-28       Impact factor: 5.372

10.  High-mobility group box 1 protein in CSF of patients with subarachnoid hemorrhage.

Authors:  Takashi Nakahara; Ryosuke Tsuruta; Tadashi Kaneko; Susumu Yamashita; Motoki Fujita; Shunji Kasaoka; Teruto Hashiguchi; Michiyasu Suzuki; Ikuro Maruyama; Tsuyoshi Maekawa
Journal:  Neurocrit Care       Date:  2009-09-24       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.